Safety profile assessment of drug products used for the pathogenetic treatment of COVID19

Syraeva G.I., Mishinova S.A., Kolbin A.S., Eremenko E.O.

Open source

DOI
10.36488/cmac.2021.3.314-329
Published
9
Container
Клиническая микробиология и антимикробная химиотерапия
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36488/cmac.2021.3.314-329,
  title = {Safety profile assessment of drug products used for the pathogenetic treatment of COVID19},
  author = {Syraeva G.I. and Mishinova S.A. and Kolbin A.S. and Eremenko E.O.},
  year = {2021},
  journal = {Клиническая микробиология и антимикробная химиотерапия},
  doi = {10.36488/cmac.2021.3.314-329},
  url = {https://doi.org/10.36488/cmac.2021.3.314-329}
}

RIS

TY  - JOUR
TI  - Safety profile assessment of drug products used for the pathogenetic treatment of COVID19
AU  - Syraeva G.I.
AU  - Mishinova S.A.
AU  - Kolbin A.S.
AU  - Eremenko E.O.
PY  - 2021
JO  - Клиническая микробиология и антимикробная химиотерапия
DO  - 10.36488/cmac.2021.3.314-329
UR  - https://doi.org/10.36488/cmac.2021.3.314-329
ER  - 

APA

G.I., S., S.A., M., A.S., K., & E.O., E. (2021). Safety profile assessment of drug products used for the pathogenetic treatment of COVID19. Клиническая микробиология и антимикробная химиотерапия. https://doi.org/10.36488/cmac.2021.3.314-329

Source records